SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-049962
Filing Date
2015-08-14
Accepted
2015-08-14 17:12:05
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v417168_10q.htm 10-Q 543940
2 EXHIBIT 10.1 v417168_ex10-1.htm EX-10.1 20073
3 EXHIBIT 31 v417168_ex31.htm EX-31 9054
4 EXHIBIT 32 v417168_ex32.htm EX-32 5114
  Complete submission text file 0001144204-15-049962.txt   6228741

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vgen-20150630.xml EX-101.INS 1595558
6 XBRL TAXONOMY EXTENSION SCHEMA vgen-20150630.xsd EX-101.SCH 51806
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vgen-20150630_cal.xml EX-101.CAL 42239
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vgen-20150630_def.xml EX-101.DEF 356596
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vgen-20150630_lab.xml EX-101.LAB 389803
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vgen-20150630_pre.xml EX-101.PRE 415432
Mailing Address 949 FELL STREET BALTIMORE MD 21231
Business Address 949 FELL STREET BALTIMORE MD 21231 410-387-4000
VACCINOGEN INC (Filer) CIK: 0001453001 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD
Type: 10-Q | Act: 34 | File No.: 000-54997 | Film No.: 151057032
SIC: 2834 Pharmaceutical Preparations